Daniel Abankwa

Daniel Abankwa is a Full Professor in Cellular Tumour Biology at the University of Luxembourg, affiliated with the Faculty of Science, Technology and Medicine and the Department of Life Sciences and Medicine. His research focuses on Ras protein signaling, nanocluster dynamics, and therapeutic strategies for KRAS-mutant cancers, employing advanced biophysical and molecular techniques.

Research interests center on cellular tumor biology, including Ras isoform specificity, drug-target interactions, and cancer cell stemness. His work integrates molecular assays, fluorescence imaging, and high-throughput screening to dissect oncogenic mechanisms and develop precision oncology approaches.

Recent publications emphasize KRAS pathway inhibition, BRET-based protein interaction analysis, and nanocluster disruption, reflecting a multidisciplinary approach spanning biophysics, pharmacology, and structural biology. Studies frequently explore therapeutic synergies, mechanistic modeling, and innovative assay development.

No awards, advising relationships, grants, or lab affiliations are detailed in the provided text.